Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
Learn about the latest developments in prostate cancer diagnosis and treatment in this 30-minute webinar presented by Dr. Ephraim Parent, Associate Professor of Radiology at Mayo Clinic. Explore FDA-approved radiopharmaceuticals used for staging and identifying local and metastatic prostate cancer, including the recently approved 68GaPSMA-11 and 18F-DCFPyL. Gain insights into the scientific rationale behind PSMA PET imaging and targeted radionuclide therapy, with special focus on the newly approved 177Lu PSMA-617 (Pluvicto) treatment. Understand the practical aspects of therapy administration and expected outcomes in both academic and small practice settings. Delivered by a dual-boarded radiologist and nuclear medicine physician with extensive research experience in neuroendocrine prostate cancer transformation and intracranial malignancies imaging.
